Clinical Trial Update: IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study (IMPACT) is evaluating certolizumab pegol to improve pregnancy outcomes in antiphospholipid syndrome during high-risk pregnancies; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Lupus Anticoagulant Disorder

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: David Ware Branch | Conditions: High Risk Pregnancy, Pregnancy Complications | Phase 2 | Status: RECRUITING